Hepatitis C Viral RNA

What the laboratory says this test is for

This panel is useful in assessing the risk of any underlying medical conditions prior, during, and after initiation of therapy for Hepatitis C. This baseline profile does not include Hepatitis A or Hepatitis B testing, under the assumption this testing has already been performed. If these tests are desired, consider using 91704 (Hepatitis C-Infected Patient, Baseline Panel 1) or ordering separately. The relevant laboratory monitoring has been defined in the most recent AASLD guidelines.

What the laboratory says this test is for

Hepatitis C patients should be monitored during therapy to assess both response to therapy as well as evaluation for side effects.

What the laboratory says this test is for

This panel is important to baseline the laboratory parameters in order to define change on therapy as well as to assess the risk of any underlying medical conditions prior to initiation of therapy for Hepatitis C.